Véronique Debien, Medical Oncologist at Institute Bergonié, shared a post on LinkedIn:
“Just back from the 7th edition of the Early Phase Clinical Trials Day Rencontre Phases Précoces en Cancérologie in Paris .
An inspiring day highlighting the strong commitment of the ANSM Agence nationale de sécurité du médicament et des produits de santé and the major stakeholders in early-phase research in France to accelerate access to innovation for our patients. Excited to see the Fast Track pathway becoming applicable soon, another step toward bringing promising therapies to the clinic faster.
It was also a great moment to reflect on how far we’ve come: this year marks the 15th anniversary of the CLIP2 network, Institut national du cancer, France’s dedicated early-phase clinical trial structures, and we’re proud that one of them is at Institut Bergonié.
Finally, a valuable reminder that beyond science, organizational excellence is our backbone, and that precision medicine is a medical necessity, not a luxury. Grateful to be part of a community striving to do better for every patient.”
More posts featuring Véronique Debien on OncoDaily.